Meta-analysis of the immune effects of inactivated H7N9 influenza vaccine / 预防医学
Journal of Preventive Medicine
; (12): 265-270, 2019.
Article
de Zh
| WPRIM
| ID: wpr-815755
Bibliothèque responsable:
WPRO
ABSTRACT
Objective @#To evaluate the immune effects of inactivated H7N9 influenza vaccine.@*Methods @#We searched several common databases(The Cochrane Library,PubMed,China Biology Medicine disc,China National Knowledge Infrastructure,etc.)for research articles about immune effects of H7N9 influenza vaccine published from the time the database built to July 10th of 2018,using H7N9 and vaccine as keywords. After screening the articles according to the inclusion and exclusion criteria,we assessed the quality of the studies and then employed seroconversion rate(SCR)as an outcome indicator to analyze the immune effects of different doses and adjuvants.@*Results @#We recruited 5 articles on inactivated H7N9 influenza vaccine from 1 679 articles. The sample size was 2 579. The results of the meta-analysis showed that the rate difference(RD)values of SCR in each dose group after the first dose ranged from 1% to 10%,which indicated a poor protective effect;after the second dose of immunization,the RD values of SCR in the vaccines without adjuvants ranged from 13% to 19%,which was not effective enough;the RD values of SCR in the vaccines with adjuvants ranged from 62% to 69%,which met the licensing criteria for influenza vaccine;better results could be achieved when immunized with two doses of vaccines with adjuvants( RR=1.19,95%CI:1.02-1.39);vaccines with AS03 or MF59 at the lowest dose of 3.75 μg had the same immune effects as ones at a dose of 15 μg;vaccines with AS03(RD=89%,95%CI:85%-93%)were superior to those with MF59(RD=42%,95%CI:9%- 75%).@*Conclusion @#Inactivated H7N9 influenza vaccines could achieve good immune effects when inoculated two doses with adjuvants,and the minimum effective dose was 3.75 μg.
Texte intégral:
1
Indice:
WPRIM
Type d'étude:
Systematic_reviews
langue:
Zh
Texte intégral:
Journal of Preventive Medicine
Année:
2019
Type:
Article